Overview of early response assessment in lymphoma with FDG-PET. - Wikidata - awgldk - TriplyDB

Overview of early response assessment in lymphoma with FDG-PET.

Overview of early response assessment in lymphoma with FDG-PET.

http://www.wikidata.org/entity/Q36927213

about

Assessment of chemotherapy response in non-Hodgkin lymphoma involving the neck utilizing diffusion kurtosis imaging: a preliminary study Opportunities for PET to deliver clinical benefit in cancer: breast cancer as a paradigm Early complete response during chemotherapy predicts favorable outcome in patients with primary CNS lymphoma.From RECIST to PERCIST: Evolving Considerations for PET response criteria in solid tumors.18F-FDG PET/CT imaging in oncology Metabolic Activity by 18F-FDG-PET/CT Is Prognostic for Stage I and II Pancreatic Cancer Baseline total lesion glycolysis measured with (18)F-FDG PET/CT as a predictor of progression-free survival in diffuse large B-cell lymphoma: a pilot study.What is the role of 18F-fluorodeoxyglucose positron emission tomography in mantle cell lymphoma?Interim fluorodeoxyglucose positron emission tomography for early response assessment in diffuse large B cell lymphoma: where are we now?Role of PET/CT imaging in stereotactic body radiotherapy.FDG-PET/CT response evaluation during EGFR-TKI treatment in patients with NSCLC.Beyond Correlations, Sensitivities, and Specificities: A Roadmap for Demonstrating Utility of Advanced Imaging in Oncology Treatment and Clinical Trial Design.The impact of positron emission tomography (PET) on expected management during cancer treatment: findings of the National Oncologic PET Registry.Increased Expression of the Glucose Transporter Type 1 Gene Is Associated With Worse Overall Survival in Resected Pancreatic Adenocarcinoma.Favorable outcome in non-Hodgkin lymphoma of the maxillary sinus treated with R-CHOP.Three-dimensional texture analysis of contrast enhanced CT images for treatment response assessment in Hodgkin lymphoma: comparison with F-18-FDG PET.Positron emission tomography scanning: a new paradigm for the management of Hodgkin's lymphoma.Interim positron emission tomography scan in Hodgkin lymphoma: definitions, interpretation rules, and clinical validation.Evaluating the place of 18-fluoro-2-deoxy-D-glucose positron emission tomography scanning in primary staging and beyond in patients with follicular lymphoma.Role of [18F]-FDG-PET/MDCT in evaluating early response in patients with Hodgkin's lymphoma.High FDG activity in focal fat necrosis: a pitfall in interpretation of posttreatment PET/CT in patients with non-Hodgkin lymphoma.Changes in (18)F-fluorothymidine and (18)F-fluorodeoxyglucose positron emission tomography imaging in patients with head and neck cancer treated with chemoradiotherapy.

P2860

Q33620670-6A1D83F9-485D-45B7-9509-736C5464E5EA Q33994282-0F26D987-B3D0-4874-946F-B8587D7B30A8 Q34132992-652EE433-9DE8-4802-95CF-440BFA1EF039 Q34978457-84C5576D-130E-4DBA-8E2A-B935940D41C6 Q35006097-0FC45ED3-1CDB-4464-9342-3877EF059EE0 Q36540475-3AF76DE0-C7D4-4A5D-B11E-3072A059EC27 Q36769240-D6CCB793-69A2-4E8E-AE8D-606A0EDA4E12 Q37271814-99FE1195-A997-4A95-9D47-65C6C03AF00A Q37650211-50F6C47A-9E84-40D7-80EA-3F1DE66CDD58 Q37690317-8B8197AA-C30E-45B8-AFBF-417912F95B83 Q38234978-A6A244C2-28C5-419C-8B9F-11B523175791 Q39272347-A74AF749-7D86-4662-A597-57AEB6113D14 Q40027009-5129F604-5B7A-4F7E-880F-824FAF0CFB57 Q40182987-9258224F-FA12-4F5F-9140-180FCD77455C Q40184260-CA4F7C75-C4E9-4B1D-84F0-B3DAC6C373F9 Q41730322-AD87964B-C32A-484C-9343-EEEC8C65827B Q42739969-F85252C5-F21A-40EC-832F-2F84F14759E3 Q43250306-F9C69A06-5A7C-4324-96F3-3C30E6545DAE Q43792807-AE5DDDD4-D08F-4B70-897F-6EC53FB9CAFE Q45394964-5D62E3B7-CC3B-4EDE-A8B4-E1FF93D64CBA Q45731504-CC9BD7FC-BA18-4A79-83B9-61D055DE42CF Q53122101-2C9D975D-B01C-4ADD-A438-37E41B8DCC78

P2860

Overview of early response assessment in lymphoma with FDG-PET.

http://www.wikidata.org/entity/Q36927213

description

2007 nî lūn-bûn

@nan

2007年の論文

@ja

2007年論文

@yue

2007年論文

@zh-hant

2007年論文

@zh-hk

2007年論文

@zh-mo

2007年論文

@zh-tw

2007年论文

@wuu

2007年论文

@zh

2007年论文

@zh-cn

name

Overview of early response assessment in lymphoma with FDG-PET.

@en

type

label

Overview of early response assessment in lymphoma with FDG-PET.

@en

prefLabel

Overview of early response assessment in lymphoma with FDG-PET.

@en

P1433

Q36927213-BCD20207-C6C2-4208-9EFA-B66AC489D948

P1476

Q36927213-9F5855D9-4F13-4A55-B861-812AA5A0F1B2

P2093

Q36927213-43F96CC0-FD9C-477B-AC6A-65D1723B917C

Q36927213-AD6ADF83-1608-44B7-97ED-CAB8C35CD358

P2860

Q36927213-0AE04AF9-E45B-4752-BAFB-0F4130EC7FF7

Q36927213-0C73E3A6-E830-48C7-8FAB-3A4E46816127

Q36927213-0C88FFF7-46B6-49F0-81CC-8F99B4EBFCA0

Q36927213-0FC091D7-C6A3-4B4A-A844-062BE5AAA77B

Q36927213-17B76F09-5898-4EFB-B190-BD6ED23760E9

Q36927213-18B2FC7C-54BB-4F6A-8464-626479786E2D

Q36927213-27A444D2-7105-44FF-8D79-2601428BD3CD

Q36927213-2CABAE25-F822-4865-B08E-F21A7BFDF687

Q36927213-318229A3-7D40-4665-85EC-370CBBF4FBBE

Q36927213-34F2D783-47A6-4ED3-B149-2BFAE02F855C

P304

Q36927213-41DC571B-D55E-4AC6-A944-8B5A76EA58A3

P31

Q36927213-B542DF00-C6A6-4BAB-8676-726663E1B16E

Q36927213-DD99027B-769B-4BF5-885F-A3B78D8881CE

P356

Q36927213-E37083C1-E1E3-443A-AF17-00EFD9BA5AB1

P478

Q36927213-319880B2-7EB1-4739-B4BD-5059525D79C7

P50

Q36927213-710A363A-F009-4259-81AB-0142B9A0F318

P577

Q36927213-742933D1-1BB8-45E0-ACA3-64EC1748965D

P5875

Q36927213-DD5BFF78-0DB8-47E2-8321-985CE29B2946

P698

Q36927213-CCF91631-55F0-41AE-AEBB-1702942CBBEB

P921

Q36927213-537DBC03-8D80-4655-B6AD-E48120C5BB19

Q36927213-A51A6402-C1AF-4031-8973-555929BC70AE

Q36927213-BFC22E6D-5F52-483A-83B8-7F6BA65162E8

Q36927213-CD905BC8-9108-4CAA-B64D-76BA0E82334C

P932

Q36927213-EEF64782-FCF5-4AFF-8F78-5FAFC666BB2A

P356

1470-7330.2007.0004

P1433

P1476

Overview of early response assessment in lymphoma with FDG-PET.

@en

P2093

John F Seymour

http://www.w3.org/2001/XMLSchema#string

Michael P MacManus

http://www.w3.org/2001/XMLSchema#string

P2860

A predictive model for aggressive non-Hodgkin's lymphoma. The International Non-Hodgkin's Lymphoma Prognostic Factors Project

Prognostic value of positron emission tomography (PET) with fluorine-18 fluorodeoxyglucose ([18F]FDG) after first-line chemotherapy in non-Hodgkin's lymphoma: is [18F]FDG-PET a valid alternative to conventional diagnostic methods?

Report of an international workshop to standardize response criteria for non-Hodgkin's lymphomas. NCI Sponsored International Working Group.

Measurement of clinical and subclinical tumour response using [18F]-fluorodeoxyglucose and positron emission tomography: review and 1999 EORTC recommendations. European Organization for Research and Treatment of Cancer (EORTC) PET Study Group.

Monitoring response to therapy in cancer using [18F]-2-fluoro-2-deoxy-D-glucose and positron emission tomography: an overview of different analytical methods.

A prognostic score for advanced Hodgkin's disease. International Prognostic Factors Project on Advanced Hodgkin's Disease.

Report of a committee convened to discuss the evaluation and staging of patients with Hodgkin's disease: Cotswolds meeting.

New treatment options have changed the survival of patients with follicular lymphoma.

Early response to chemotherapy: a surrogate for final outcome of Hodgkin's disease patients that should influence initial treatment length and intensity?

Gallium-67 scintigraphy: a cornerstone in functional imaging of lymphoma.

P304

10-18

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1102/1470-7330.2007.0004

http://www.w3.org/2001/XMLSchema#string

P478

7

http://www.w3.org/2001/XMLSchema#string

P50

Rodney J. Hicks

P577

2007-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

6074657

http://www.w3.org/2001/XMLSchema#string

P698

17766210

http://www.w3.org/2001/XMLSchema#string

P921

Angliavandeniai

inorganic compound

mechanism of action

P932

1974859

http://www.w3.org/2001/XMLSchema#string